Avandia (rosiglitazone), a medication for people with type 2 diabetes, has been the subject of studies evaluating its safety and the results aren’t what Glaxo (the manufacturer) had hoped for. According to researchers in Toronto, Canada, elderly people who take Avandia may have an increased risk of heart failure and death.
The researchers didn’t, however, find the same results that American researchers found two years earlier, which suggested that Avandia also increased the risk of heart attacks. The Canadian researchers found no difference between patients who took Avandia and another type of medication, Actos (pioglitazone), and the rate of heart attacks …read more